|
ARID1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54759982606834E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03850039678832E-10 |
| Normal-vs-Stage2 |
1.04590000005178E-06 |
| Normal-vs-Stage3 |
4.25229999989618E-07 |
| Normal-vs-Stage4 |
3.82880000038277E-07 |
| Stage1-vs-Stage2 |
8.687200E-01 |
| Stage1-vs-Stage3 |
9.831600E-01 |
| Stage1-vs-Stage4 |
4.362200E-01 |
| Stage2-vs-Stage3 |
8.853400E-01 |
| Stage2-vs-Stage4 |
4.791400E-01 |
| Stage3-vs-Stage4 |
3.942800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.08099973417097E-10 |
| Normal-vs-AfricanAmerican |
1.82210002641625E-09 |
| Normal-vs-Asian |
4.45840000000697E-05 |
| Caucasian-vs-AfricanAmerican |
5.720800E-01 |
| Caucasian-vs-Asian |
2.412200E-01 |
| AfricanAmerican-vs-Asian |
7.137800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.1020961920849E-11 |
| Normal-vs-Female |
1.234270E-04 |
| Male-vs-Female |
1.742240E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.68800000538627E-08 |
| Normal-vs-Extreme_Weight |
2.45992115566196E-12 |
| Normal-vs-Obese |
5.34690000053573E-07 |
| Normal-vs-Extreme_Obese |
4.55540000054988E-07 |
| Normal_Weight-vs-Extreme_Weight |
4.278000E-01 |
| Normal_Weight-vs-Obese |
2.700800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.600200E-01 |
| Extreme_Weight-vs-Obese |
3.081800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.622400E-01 |
| Obese-vs-Extreme_Obese |
1.633580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.776300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.79889999563088E-08 |
| Normal-vs-Age(61-80Yrs) |
7.4762418478258E-12 |
| Normal-vs-Age(81-100Yrs) |
2.11720000420357E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.860400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.472000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.241700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.038100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.901500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.281000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.03700406437224E-11 |
| Normal-VS-Type2 PRCC |
1.03109742966012E-11 |
| Normal-VS-KIRP CIMP |
9.930000E-02 |
| Normal-VS-Unclassified PRCC |
8.176400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.167800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.372640E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.785700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.232100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.132200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.032200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.37143638059933E-13 |
| Normal-vs-N1 |
4.807400E-04 |
| Normal-vs-N2 |
7.244600E-03 |
| N0-vs-N1 |
2.585700E-02 |
| N0-vs-N2 |
3.606800E-01 |
| N1-vs-N2 |
8.300200E-01 |
|
|
